Psilocybin-induced changes in cerebral blood flow are associated with acute and baseline inter-individual differences by Nathalie M. Rieser, Ladina P. Gubser, Flora Moujaes, Patricia Duerler, Candace R. Lewis, Lars Michels, Franz X. Vollenweider, Katrin H. Preller

Get full text

The Predictive Value of Impulsivity and Risk-Taking Measures for Substance Use in Substance Dependent Offenders by Nathalie M. Rieser, Lilach Shaul, Matthijs Blankers, Matthijs Blankers, Matthijs Blankers, Maarten W. J. Koeter, Gerard M. Schippers, Anna E. Goudriaan, Anna E. Goudriaan

Get full text

Corrigendum to ‘Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial’ by Robin von Rotz, Eva M. Schindowski, Johannes Jungwirth, Anna Schuldt, Nathalie M. Rieser, Katharina Zahoranszky, Erich Seifritz, Albina Nowak, Peter Nowak, Lutz Jäncke, Katrin H. Preller, Franz X. Vollenweider

Get full text

Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trialResearch in context by Robin von Rotz, Eva M. Schindowski, Johannes Jungwirth, Anna Schuldt, Nathalie M. Rieser, Katharina Zahoranszky, Erich Seifritz, Albina Nowak, Peter Nowak, Lutz Jäncke, Katrin H. Preller, Franz X. Vollenweider

Get full text